178 related articles for article (PubMed ID: 12824887)
41. Expression of PTEN, PPM1A and P-Smad2 in hepatocellular carcinomas and adjacent liver tissues.
Wu SK; Wang BJ; Yang Y; Feng XH; Zhao XP; Yang DL
World J Gastroenterol; 2007 Sep; 13(34):4554-9. PubMed ID: 17729405
[TBL] [Abstract][Full Text] [Related]
42. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
[TBL] [Abstract][Full Text] [Related]
43. Enhanced expression of mRNAs of antisecretory factor-1, gp96, DAD1 and CDC34 in human hepatocellular carcinomas.
Tanaka K; Kondoh N; Shuda M; Matsubara O; Imazeki N; Ryo A; Wakatsuki T; Hada A; Goseki N; Igari T; Hatsuse K; Aihara T; Horiuchi S; Yamamoto N; Yamamoto M
Biochim Biophys Acta; 2001 Apr; 1536(1):1-12. PubMed ID: 11335099
[TBL] [Abstract][Full Text] [Related]
44. Expression of human macrophage metalloelastase gene in hepatocellular carcinoma: correlation with angiostatin generation and its clinical significance.
Gorrin Rivas MJ; Arii S; Furutani M; Harada T; Mizumoto M; Nishiyama H; Fujita J; Imamura M
Hepatology; 1998 Oct; 28(4):986-93. PubMed ID: 9755235
[TBL] [Abstract][Full Text] [Related]
45. Evidence for heightened hexokinase II immunoexpression in hepatocyte dysplasia and hepatocellular carcinoma.
Guzman G; Chennuri R; Chan A; Rea B; Quintana A; Patel R; Xu PZ; Xie H; Hay N
Dig Dis Sci; 2015 Feb; 60(2):420-6. PubMed ID: 25381201
[TBL] [Abstract][Full Text] [Related]
46. Overexpression of p28/gankyrin in human hepatocellular carcinoma and its clinical significance.
Fu XY; Wang HY; Tan L; Liu SQ; Cao HF; Wu MC
World J Gastroenterol; 2002 Aug; 8(4):638-43. PubMed ID: 12174370
[TBL] [Abstract][Full Text] [Related]
47. [Determination and the significance of three types of GGT mRNA in human liver tissues].
Han G; Qin C
Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):126-8. PubMed ID: 11983133
[TBL] [Abstract][Full Text] [Related]
48. Prognostic value of long non-coding RNA
Liao X; Chen J; Luo D; Luo B; Huang W; Xie W
Pathol Oncol Res; 2022; 28():1610808. PubMed ID: 36685103
[No Abstract] [Full Text] [Related]
49. Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanism.
Sureban SM; Madhoun MF; May R; Qu D; Ali N; Fazili J; Weygant N; Chandrakesan P; Ding K; Lightfoot SA; Houchen CW
Oncotarget; 2015 Nov; 6(35):37200-15. PubMed ID: 26468984
[TBL] [Abstract][Full Text] [Related]
50. Decreased expression of cytochrome P450 2E1 is associated with poor prognosis of hepatocellular carcinoma.
Ho JC; Cheung ST; Leung KL; Ng IO; Fan ST
Int J Cancer; 2004 Sep; 111(4):494-500. PubMed ID: 15239125
[TBL] [Abstract][Full Text] [Related]
51. TREM-1, an inflammatory modulator, is expressed in hepatocellular carcinoma cells and significantly promotes tumor progression.
Duan M; Wang ZC; Wang XY; Shi JY; Yang LX; Ding ZB; Gao Q; Zhou J; Fan J
Ann Surg Oncol; 2015 Sep; 22(9):3121-9. PubMed ID: 25465376
[TBL] [Abstract][Full Text] [Related]
52. Decreased expression of the human carbonyl reductase 2 gene HCR2 in hepatocellular carcinoma.
Liu S; Ma L; Huang W; Shai Y; Ji X; Ding L; Liu Y; Yu L; Zhao S
Cell Mol Biol Lett; 2006; 11(2):230-41. PubMed ID: 16847567
[TBL] [Abstract][Full Text] [Related]
53. Expression and alteration of insulin-like growth factor II-messenger RNA in hepatoma tissues and peripheral blood of patients with hepatocellular carcinoma.
Dong ZZ; Yao DF; Yao DB; Wu XH; Wu W; Qiu LW; Jiang DR; Zhu JH; Meng XY
World J Gastroenterol; 2005 Aug; 11(30):4655-60. PubMed ID: 16094705
[TBL] [Abstract][Full Text] [Related]
54. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX
Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356
[TBL] [Abstract][Full Text] [Related]
55. Integrative transcriptome analysis of liver cancer profiles identifies upstream regulators and clinical significance of ACSM3 gene expression.
Gopal R; Selvarasu K; Pandian PP; Ganesan K
Cell Oncol (Dordr); 2017 Jun; 40(3):219-233. PubMed ID: 28390038
[TBL] [Abstract][Full Text] [Related]
56. KAP1 is overexpressed in hepatocellular carcinoma and its clinical significance.
Wang Y; Jiang J; Li Q; Ma H; Xu Z; Gao Y
Int J Clin Oncol; 2016 Oct; 21(5):927-933. PubMed ID: 27095111
[TBL] [Abstract][Full Text] [Related]
57. Expression of survivin messenger RNA correlates with poor prognosis in patients with hepatocellular carcinoma.
Ikeguchi M; Ueda T; Sakatani T; Hirooka Y; Kaibara N
Diagn Mol Pathol; 2002 Mar; 11(1):33-40. PubMed ID: 11854600
[TBL] [Abstract][Full Text] [Related]
58. Overexpression of beta 1,4N-acetylgalactosaminyl- transferase mRNA as a molecular marker for various types of cancers.
Sugita Y; Fujiwara Y; Hoon DS; Miyamoto A; Sakon M; Kuo CT; Monden M
Oncology; 2002; 62(2):149-56. PubMed ID: 11914601
[TBL] [Abstract][Full Text] [Related]
59. Carboxypeptidase E is a prediction marker for tumor recurrence in early-stage hepatocellular carcinoma.
Huang SF; Wu HD; Chen YT; Murthy SR; Chiu YT; Chang Y; Chang IC; Yang X; Loh YP
Tumour Biol; 2016 Jul; 37(7):9745-53. PubMed ID: 26803519
[TBL] [Abstract][Full Text] [Related]
60. Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma.
Chiba T; Saito T; Yuki K; Zen Y; Koide S; Kanogawa N; Motoyama T; Ogasawara S; Suzuki E; Ooka Y; Tawada A; Otsuka M; Miyazaki M; Iwama A; Yokosuka O
Int J Cancer; 2015 Jan; 136(2):289-98. PubMed ID: 24844570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
